Organ-on-a-chip systems possess a promising future as drug screening assays and as testbeds for disease modeling in the context of both single-organ systems and multi-organ-chips. Although it comprises approximately one fourth of the body weight of a healthy human, an organ frequently overlooked in this context is white adipose tissue (WAT). WAT-on-a-chip systems are required to create safety profiles of a large number of drugs due to their interactions with adipose tissue and other organs via paracrine signals, fatty acid release, and drug levels through sequestration. We report a WAT-on-a-chip system with a footprint of less than 1 mm(2) consisting of a separate media channel and WAT chamber connected via small micropores. Analogous to th...
Obesity is a complex and incompletely understood disease, but current drug screening strategies most...
The ever growing amount of new substances released onto the market and the limited predictability of...
Overcoming the challenges that the pharmaceutical industry currently faces requires the development ...
Drug discovery and development to date has relied on animal models, which are useful, but fail to re...
Human fat tissue has evolved to serve as a major energy reserve. An imbalance between energy intake ...
Background and aims: Type 2 Diabetes Mellitus is a complex disease affecting many pathways in differ...
Microfluidic devices can be used to perform sophisticated cell physiology experiments. Additionally,...
Human tissue in vitro models on-chip are highly desirable to dissect the complexity of a physio-path...
Human tissue in vitro models on-chip are highly desirable to dissect the complexity of a physio-path...
The adipose tissue is a metabolically active endocrine organ with a dynamic secretome that is known ...
Obesity, defined as a body mass index of 30 kg/m2 or above, has increased considerably in incidence ...
Patients around the world who suffer from a host of debilitating conditions rely on medications for ...
In this work, we present a triple-organ co-culture between 3 metabolic organs (Skeletal Muscle, Adip...
Over the decades, conventional in vitro culture systems and animal models have been used to study ph...
Modeling the human physiology in vitro is a challenging task, yet one of importance for the developm...
Obesity is a complex and incompletely understood disease, but current drug screening strategies most...
The ever growing amount of new substances released onto the market and the limited predictability of...
Overcoming the challenges that the pharmaceutical industry currently faces requires the development ...
Drug discovery and development to date has relied on animal models, which are useful, but fail to re...
Human fat tissue has evolved to serve as a major energy reserve. An imbalance between energy intake ...
Background and aims: Type 2 Diabetes Mellitus is a complex disease affecting many pathways in differ...
Microfluidic devices can be used to perform sophisticated cell physiology experiments. Additionally,...
Human tissue in vitro models on-chip are highly desirable to dissect the complexity of a physio-path...
Human tissue in vitro models on-chip are highly desirable to dissect the complexity of a physio-path...
The adipose tissue is a metabolically active endocrine organ with a dynamic secretome that is known ...
Obesity, defined as a body mass index of 30 kg/m2 or above, has increased considerably in incidence ...
Patients around the world who suffer from a host of debilitating conditions rely on medications for ...
In this work, we present a triple-organ co-culture between 3 metabolic organs (Skeletal Muscle, Adip...
Over the decades, conventional in vitro culture systems and animal models have been used to study ph...
Modeling the human physiology in vitro is a challenging task, yet one of importance for the developm...
Obesity is a complex and incompletely understood disease, but current drug screening strategies most...
The ever growing amount of new substances released onto the market and the limited predictability of...
Overcoming the challenges that the pharmaceutical industry currently faces requires the development ...